MedPath
TGA Approval

Idarubicin Injection 20 mg/20 mL (3) (405009)

405009

Idarubicin Injection 20 mg/20 mL (3)

Pfizer (Perth) Pty Ltd

February 17, 2023

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

idarubicin hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.